Literature DB >> 17183014

Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.

Jaume Marrugat1, Isaac Subirana, Eva Comín, Carmen Cabezas, Joan Vila, Roberto Elosua, Byung-Ho Nam, Rafel Ramos, Joan Sala, Pascual Solanas, Ferran Cordón, Joan Gené-Badia, Ralph B D'Agostino.   

Abstract

BACKGROUND: To assess the reliability and accuracy of the Framingham coronary heart disease (CHD) risk function adapted by the Registre Gironí del Cor (REGICOR) investigators in Spain.
METHODS: A 5-year follow-up study was completed in 5732 participants aged 35-74 years. The adaptation consisted of using in the function the average population risk factor prevalence and the cumulative incidence observed in Spain instead of those from Framingham in a Cox proportional hazards model. Reliability and accuracy in estimating the observed cumulative incidence were tested with the area under the curve comparison and goodness-of-fit test, respectively.
RESULTS: The Kaplan-Meier CHD cumulative incidence during the follow-up was 4.0% in men and 1.7% in women. The original Framingham function and the REGICOR adapted estimates were 10.4% and 4.8%, and 3.6% and 2.0%, respectively. The REGICOR-adapted function's estimate did not differ from the observed cumulated incidence (goodness of fit in men, p = 0.078, in women, p = 0.256), whereas all the original Framingham function estimates differed significantly (p<0.001). Reliabilities of the original Framingham function and of the best Cox model fit with the study data were similar in men (area under the receiver operator characteristic curve 0.68 and 0.69, respectively, p = 0.273), whereas the best Cox model fitted better in women (0.73 and 0.81, respectively, p<0.001).
CONCLUSION: The Framingham function adapted to local population characteristics accurately and reliably predicted the 5-year CHD risk for patients aged 35-74 years, in contrast with the original function, which consistently overestimated the actual risk.

Entities:  

Mesh:

Year:  2007        PMID: 17183014      PMCID: PMC2465597          DOI: 10.1136/jech.2005.038505

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  28 in total

1.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study.

Authors:  W M Verschuren; D R Jacobs; B P Bloemberg; D Kromhout; A Menotti; C Aravanis; H Blackburn; R Buzina; A S Dontas; F Fidanza
Journal:  JAMA       Date:  1995-07-12       Impact factor: 56.272

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

4.  Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998.

Authors:  Jaume Marrugat; Roberto Elosua; Elena Aldasoro; María José Tormo; Hermelinda Vanaclocha; Antonio Segura; Miquel Fiol; Concepción Moreno-Iribas; Gloria Pérez; José María Arteagoitia; Lluis Cirera; Adolfo Cabadés; Gema Vega; José Ignacio Ayestarán; Vega García; Iraida Hurtado-de-Saracho; José García; Oscar Zurriaga; Javier Muñiz; Joan Sala
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].

Authors:  Rafael Ramos; Pascual Solanas; Ferran Cordón; Izabella Rohlfs; Roberto Elosua; Joan Sala; Rafael Masiá; María Teresa Faixedas; Jaume Marrugat
Journal:  Med Clin (Barc)       Date:  2003-10-25       Impact factor: 1.725

6.  Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.

Authors:  Jing Liu; Yuling Hong; Ralph B D'Agostino; Zhaosu Wu; Wei Wang; Jiayi Sun; Peter W F Wilson; William B Kannel; Dong Zhao
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

7.  Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox.

Authors:  S M Artaud-Wild; S L Connor; G Sexton; W E Connor
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

8.  Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.

Authors:  Chong Do Lee; Aaron R Folsom; James S Pankow; Frederick L Brancati
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

9.  Concept and usefulness of cardiovascular risk profiles.

Authors:  William B Kannel; Ralph B D'Agostino; Lisa Sullivan; Peter W F Wilson
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

10.  Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Authors:  Peter Brindle; Jonathan Emberson; Fiona Lampe; Mary Walker; Peter Whincup; Tom Fahey; Shah Ebrahim
Journal:  BMJ       Date:  2003-11-29
View more
  43 in total

1.  [Cardiovascular risk factors and Primary Care: evaluation and intervention].

Authors:  José María Lobos Bejarano; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2011-11-17       Impact factor: 1.137

2.  Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Natalio Díaz Herrera; Gerardo Fernández Ochoa; Juan Ignacio Calvo Hueros; Francisco Buitrago
Journal:  Scand J Prim Health Care       Date:  2010-09-27       Impact factor: 2.581

3.  Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Authors:  Morris Schambelan; Peter W F Wilson; Kevin E Yarasheski; W Todd Cade; Victor G Dávila-Román; Ralph B D'Agostino; Tarek A Helmy; Matthew Law; Kristin E Mondy; Sharon Nachman; Linda R Peterson; Signe W Worm
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

4.  Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.

Authors:  Francisco Buitrago; Juan Ignacio Calvo-Hueros; Lourdes Cañón-Barroso; Gerónimo Pozuelos-Estrada; Luis Molina-Martínez; Manuel Espigares-Arroyo; Juan Antonio Galán-González; Francisco J Lillo-Bravo
Journal:  Ann Fam Med       Date:  2011 Sep-Oct       Impact factor: 5.166

5.  Improving interMediAte risk management. MARK study.

Authors:  Ruth Martí; Dídac Parramon; Luís García-Ortiz; Fernando Rigo; Manuel A Gómez-Marcos; Irene Sempere; Natividad García-Regalado; Jose I Recio-Rodriguez; Cristina Agudo-Conde; Natalia Feuerbach; Maria Garcia-Gil; Anna Ponjoan; Miquel Quesada; Rafel Ramos
Journal:  BMC Cardiovasc Disord       Date:  2011-10-13       Impact factor: 2.298

6.  Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?

Authors:  Maria Del Mar Vila; Beatriz Remeseiro; Laura Igual; Roberto Elosua; Rafel Ramos; Jose Manuel Valdivielso; Ruth Martí-Lluch; Jaume Marrugat; Maria Grau
Journal:  Hypertens Res       Date:  2021-04-08       Impact factor: 3.872

7.  Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study).

Authors:  Maria Rubio-Valera; Antoni Serrano-Blanco; Ignacio Aznar-Lou; Edurne Zabaleta-Del-Olmo; Marc Casajuana-Closas; Alba Sánchez-Viñas; Elizabeth Parody-Rúa; Bonaventura Bolíbar; Montserrat Iracheta-Todó; Oana Bulilete; Tomàs López-Jiménez; Haizea Pombo-Ramos; María Victoria Martín Miguel; Rosa Magallón-Botaya; Jose Ángel Maderuelo-Fernández; Emma Motrico; Juan Bellón; Ruth Martí-Lluch
Journal:  Int J Behav Nutr Phys Act       Date:  2021-07-02       Impact factor: 6.457

8.  Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others.

Authors:  Miquel Bennasar-Veny; Angel A Lopez-Gonzalez; Pedro Tauler; Mey L Cespedes; Teofila Vicente-Herrero; Aina Yañez; Matias Tomas-Salva; Antoni Aguilo
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  Impact of a self-care education programme on patients with type 2 diabetes in primary care in the Basque Country.

Authors:  Estibaliz Gamboa Moreno; Álvaro Sánchez Perez; Kalliopi Vrotsou; Juan Carlos Arbonies Ortiz; Emma Del Campo Pena; Lourdes Ochoa de Retana Garcia; María Ángeles Rua Portu; Koldo Piñera Elorriaga; Amaya Zenarutzabeitia Pikatza; Miren Nekane Urquiza Bengoa; Rosario Sanz Echave; Tomás Méndez Sampedro; Ana Oses Portu; Lourdes Gorostidi Fano; Miren Bakarne Aguirre Sorondo; Rafael Rotaeche Del Campo
Journal:  BMC Public Health       Date:  2013-05-29       Impact factor: 3.295

10.  Prevalence of obesity and associated cardiovascular risk: the DARIOS study.

Authors:  Francisco Javier Félix-Redondo; María Grau; José Miguel Baena-Díez; Irene R Dégano; Antonio Cabrera de León; Maria Jesús Guembe; María Teresa Alzamora; Tomás Vega-Alonso; Nicolás R Robles; Honorato Ortiz; Fernando Rigo; Eduardo Mayoral-Sanchez; Maria José Tormo; Antonio Segura-Fragoso; Daniel Fernández-Bergés
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.